UNCOMPROMISING
PERFORMANCE
IN A SINGLE
SYRINGE.
1-4
Validated for use
with the UltraSert
TM
Pre-loaded IOL Deliv-
ery System
Your technologies and techniques have
evolved. It's time to rethink your OVDs.
For important product information, please see adjacent page
Trust the adaptive capabilities of DisCoVisc
®
OVD to deliver the
powerful combination of:
•
Chondroitin sulfate for superior endothelial protection and retention
1-3
•
Mechanical protection, space maintenance and clarity
4
Talk to your Alcon sales representative to learn how
all-in-one DisCoVisc
®
OVD can exceed your evolving needs.
Advanced-technology compatible
Advancing
CATARACT SURGERY
DisCoVisc
®
OPHTHALMIC VISCOSURGICAL DEVICE
1. Vasavada A, Ong M, Cordova D, Hartzer M. Protective eff ect ophthalmic viscosurgical devices (OVDs) against hydrogen peroxide-induced oxidative damage to corneal endothelial cells: an in-vitro model. Presented at American Society of Cataract and Refrac-
tive Surgeons; April 3-8, 2009; San Francisco, CA. 2. Petroll WM, Jafari M, Lane SS, Jester JV, Cavanagh HD. Quantitative assessment of ophthalmic viscosurgical device retention using in vivo confocal microscopy. J Cataract Refract Surg. 2005;31(12):2363-2368.
3. Lindstrom RL, Ong M. Protective eff ect of OVDs against hydrogen peroxide-induced oxidative damage to corneal endothelial cells: in vitro model. Presented at ASCRS; 26 Mar 2011; San Diego, CA. 4. DisCoVisc
®
Package Insert.
© 2016 Novartis 2/16 US-VIS-16-E-0527
